Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 15.25
-0.25 (-1.61%)
At close: Oct 27, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €114.63 million as of October 27, 2026. It is the 23,327th most valuable company in the world and the 132nd biggest in Spain. Its market cap has increased by 138.04% in one year.
Market Cap
114.63M
Enterprise Value
112.43M
Revenue
9.69M
Global Rank
Country Rank
#132 Spain
PE Ratio
39.57
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 114.63M, an increase of 645.84%. That is a compound annual growth rate of 54.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 114.63M | 78.18% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.38B |
| Laboratorios Farmaceuticos Rovi | 3.14B |
| Almirall | 2.26B |
| Faes Farma | 1.46B |
| Clínica Baviera | 849.76M |
| Laboratorio Reig Jofre | 214.22M |
| Prim, S.A. | 211.75M |
| Oryzon Genomics | 204.91M |